Home> Products> precise dose

{ "products": [ { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Imatinib IP 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2025-12-18T07:41:25.851Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/imatinib-ip-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "693c0c9c0c30ac5c9f8203b4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Isosorbide Mononitrate IP 30mg Tablets", "description": "CARDULES ISMN SR 30 tablets provide sustained-release Isosorbide Mononitrate IP 30mg, a nitrate medication designed for long-term management of angina in patients with coronary artery disease. This formulation from Steris Healthcare Pvt Ltd ensures steady vasodilation to improve heart blood flow and reduce chest pain episodes. It supports daily activities by minimizing oxygen demand on the heart muscle.​\nProduct Overview\nCARDULES ISMN SR 30 contains Isosorbide Mononitrate IP 30mg in a sustained-release matrix, allowing once-daily dosing for consistent therapeutic levels over 12-24 hours. The tablet's extended-release technology prevents peak-trough fluctuations common in immediate-release forms, promoting better patient compliance. Each film-coated tablet delivers precise bioavailability, with the active metabolite nitric oxide activating guanylate cyclase to boost cyclic GMP, relaxing vascular smooth muscle primarily in veins.​\n\nThis mechanism reduces preload (venous return to the heart) and afterload (arterial resistance), easing cardiac workload without significantly affecting heart rate. Unlike short-acting nitrates for acute relief, CARDULES ISMN SR 30 targets prophylaxis in chronic stable angina, often prescribed alongside beta-blockers or calcium channel blockers. Available in strips of 10 tablets, it undergoes rigorous quality testing at Steris facilities to meet IP standards, ensuring purity and stability.​\n\nKey Uses\nCARDULES ISMN SR 30 primarily prevents angina pectoris in coronary artery disease, where narrowed vessels limit oxygen supply during exertion. Patients experience fewer chest pain attacks during walking, climbing stairs, or stress.​\n\nIt manages chronic stable angina by enhancing myocardial perfusion, suitable for long-term therapy in adults over 18. Healthcare providers may use it adjunctively for coronary spasm or post-myocardial infarction prophylaxis to stabilize symptoms.​\n\nIn select cases, it aids heart failure management by offloading the heart, though not as monotherapy. Always initiate under cardiology supervision with dose titration to tolerance.​\n\nMajor Benefits\nThe sustained-release profile offers 24-hour protection with single morning dosing, improving adherence and lifestyle quality for active patients. It boosts exercise tolerance by 20-30% in trials, allowing longer physical efforts without angina onset.​\n\nBy dilating vessels, it decreases ischemia risk, potentially lowering hospitalization rates for acute episodes. Compared to placebo, users report halved attack frequency within weeks, enhancing daily productivity and emotional well-being.​\n\nBenefit\tMechanism\tPatient Outcome\nAngina Prevention\tVasodilation reduces preload/afterload ​\tFewer attacks, better exertion capacity\nSteady Relief\tSR formulation maintains levels ​\tOnce-daily convenience, no fluctuations\nHeart Protection\tImproves O2 delivery ​\tReduced ischemia, enhanced QoL\nCompliance Boost\tSimple regimen ​\tHigher adherence vs multiple doses\nAdditional perks include minimal impact on blood pressure in normotensives and compatibility with anti-anginals, making it versatile in combo therapy.\n\nPotential Side Effects\nCommon effects include headache (dose-related, often transient in first week), dizziness, or flushing due to vasodilation—hydrate and rise slowly to manage. Gastrointestinal upset like nausea occurs in 5-10% initially.​\n\nOrthostatic hypotension risks fainting, especially early; avoid alcohol or other vasodilators. Rare serious issues encompass severe hypotension, tachycardia, or methemoglobinemia with overdose—monitor blood pressure regularly.​\n\nAllergic reactions (rash, itching) or vision changes warrant discontinuation. Contraindicated in hypotension, glaucoma, or recent PDE5 inhibitor use; caution in anemia or hypothyroidism.​\n\nDosage Guidelines\nStart with 30mg once daily upon waking, swallowed whole without crushing. Titrate to 60mg if tolerated after 3-7 days, max 120mg/day. Take on empty stomach for optimal absorption; avoid late dosing to prevent nocturnal headaches.​\n\nAdjust for elderly or renal/hepatic impairment. Tolerance may develop—nitrate-free interval (evening) helps sustain efficacy. Store below 30°C.​\nConclusion\nCARDULES ISMN SR 30 empowers angina patients with reliable, once-daily prevention, restoring confidence in routine activities under Steris Healthcare's quality assurance. Its targeted vasodilation balances efficacy and tolerability for sustained heart health", "price": 65.0, "discountamount": 19.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2243, "imageuri": "https://productimages.withfloats.com/actual/693c0ca6391a3fa44b0608d8.png", "tileimageuri": "https://productimages.withfloats.com/tile/693c0ca6391a3fa44b0608d8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-12T12:37:48.92Z", "updatedon": "2025-12-12T12:37:48.92Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/isosorbide-mononitrate-ip-30mg-tablets/2243", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CARDULES ISMN SR 30", "category": "", "tags": [ "Isosorbide Mononitrate IP 30mg Tablets", "coronary artery disease", "heart blood flow and reduce chest pain episodes", "oxygen demand on the heart muscle", "relaxing vascular smooth muscle primarily in veins" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "693c0a0eb7439f8802544bc8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RIBAVIRIN CAPSULES IP 100mg", "description": "REBATERIS 100 contains Ribavirin IP 100mg in a hard gelatin capsule filled with white to off-white powder for optimal stability and bioavailability. Each pack typically includes 30 capsules, designed for oral administration with food to enhance absorption and reduce gastrointestinal upset. Ribavirin, a synthetic guanosine nucleoside analog, interferes with viral RNA polymerase and mRNA capping, halting hepatitis C virus (HCV) replication at multiple stages. This broad-spectrum antiviral also shows activity against respiratory syncytial virus (RSV) in select pediatric cases, though its primary indication remains HCV genotype management.​\n\nThe 100mg strength allows for weight-based dosing adjustments, making REBATERIS 100 suitable for adults and children over 3 years under specialist supervision. Unlike higher 200mg capsules, it supports finer dose reductions during therapy to manage side effects, ensuring better tolerability. Stored at room temperature away from moisture, it maintains potency for extended shelf life, aligning with pharmacopeial standards for purity and dissolution.​\n\nKey Uses\nREBATERIS 100 treats chronic hepatitis C virus infection in combination therapies, particularly for patients ineligible for all-oral direct-acting antivirals. It boosts sustained virologic response rates when paired with pegylated interferon alfa, addressing genotypes 1 through 6 based on regional guidelines.​\n\nIn severe RSV lower respiratory tract infections, off-label use occurs in hospitalized infants, where aerosolized forms predominate, but oral REBATERIS 100 contributes to interferon combos for immunocompromised children. It curbs viral load, prevents liver fibrosis progression, and reduces cirrhosis risk, making it essential for long-term liver preservation.​\n\nAdditionally, emerging evidence supports its adjunct role in certain hemorrhagic fevers like Lassa virus, though availability limits widespread application. Always initiated by hepatologists, treatment durations span 24-48 weeks depending on genotype, viral load, and response milestones.​\n\nMajor Benefits\nREBATERIS 100 enhances viral clearance, achieving up to 50-80% sustained response rates in interferon combinations, significantly lowering hepatocellular carcinoma risk over five years. Patients experience normalized liver enzymes and fibrosis regression on biopsy follow-up.​\n\nIts oral capsule form simplifies adherence compared to injectables, with twice-daily dosing fitting daily routines. The 100mg potency permits precise titration—e.g., 800-1400mg daily divided—for personalized therapy, minimizing excess exposure in lighter patients.​\n\nLong-term, it preserves liver function, averting transplants and improving quality of life metrics like fatigue reduction and work productivity. Cost-effective for resource-limited settings, REBATERIS 100 bridges gaps until pan-genotypic regimens become accessible.​\nBenefit\tMechanism\tClinical Impact\nViral Suppression\tRNA polymerase inhibition ​\t>50% SVR in combos ​\nLiver Protection\tFibrosis halt ​\tReduced cirrhosis by 30-40%\nFlexible Dosing\t100mg increments ​\tBetter tolerability, adherence\nBroad Genotype Coverage\tMulti-genotype efficacy ​\tVersatile for diverse patients\nPotential Side Effects\nCommon side effects include hemolytic anemia, peaking at weeks 4-8, necessitating hemoglobin monitoring and dose cuts to 600mg daily if levels drop below 10g/dL. Fatigue, headache, and insomnia affect over 40% of users, often resolving post-therapy.​\n\nGastrointestinal issues like nausea, diarrhea, and anorexia occur in 20-30%, mitigated by food intake. Dermatologic reactions—rash, pruritus—or flu-like symptoms from interferon pairing demand vigilance. Teratogenicity risks are high; dual contraception is mandatory for 6 months post-treatment due to sperm/ovum mutagenicity.​\n\nSerious risks encompass pulmonary infiltrates, cardiac ischemia in vulnerable patients, and thyroid dysfunction. Avoid in hemoglobinopathies, severe renal impairment (CrCl <50mL/min), or pregnancy. Regular blood counts and ophthalmologic exams guide safe continuation.​\n\nDosage Guidelines\nDosing is weight-based: adults <75kg receive mg/day (10 capsules: 5 AM, 5 PM); ≥75kg get 1200 mg/day (12 capsules: 6 AM, 6 PM), swallowed whole with meals. Pediatrics (≥3 years): 15mg/kg/day divided BID, rounded to the nearest 100mg via REBATERIS 100 capsules.​\n\nReduce by 200-400mg for anemia or neutropenia; discontinue if unresolved. Duration: 48 weeks for genotype 1, 24 weeks for others, with viral load checks at week 12. Swallow intact; no crushing.​\nConclusion\nREBATERIS 100 empowers hepatitis C management with proven antiviral potency and dosing precision from Steris Healthcare. It transforms prognosis for countless patients, but demands specialist oversight amid monitoring needs", "price": 2900.0, "discountamount": 870.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2242, "imageuri": "https://productimages.withfloats.com/actual/693c0a151c130ff8f4cd2c93.png", "tileimageuri": "https://productimages.withfloats.com/tile/693c0a151c130ff8f4cd2c93.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-12T12:26:54.651Z", "updatedon": "2025-12-12T12:26:54.651Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ribavirin-capsules-ip-100mg/2242", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "REBATERIS 100", "category": "Gastroenterology", "tags": [ "Ribavirin IP 100mg", "HCV genotype management", "hepatitis C virus (HCV)", "RNA polymerase and mRNA capping", "respiratory tract infections", "fibrosis progression", "enzymes and fibrosis regression on biopsy" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "693c05831844c6739ab3e83a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mefenamic Acid and Paracetamol Suspension", "description": "METAPECT MF KID SUSPENSION stands out as a specialized formulation from Steris Healthcare Pvt Ltd, blending Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), with Paracetamol, a widely used analgesic and antipyretic. Typically available in a 60ml bottle with child-friendly flavoring, it contains precise concentrations like 100mg Mefenamic Acid and 250mg Paracetamol per 5ml serving, ensuring accurate dosing via the included measuring cup. This sugar-free or low-sugar variant minimizes dental risks while providing rapid absorption for faster onset compared to solid forms. Manufactured under stringent quality controls, it supports pediatric care by addressing inflammation at its source through COX enzyme inhibition, which curbs prostaglandin production responsible for pain signals and fever response.​\n\nThe suspension's dual-action mechanism sets it apart: Paracetamol targets the brain's hypothalamus to regulate body temperature and elevate pain thresholds, while Mefenamic Acid reduces tissue swelling and inflammatory mediators. This synergy makes METAPECT MF KID SUSPENSION more effective than single-ingredient options for multifaceted symptoms. Healthcare professionals often recommend it for short-term use in infants over six months and children, always under medical guidance to match age and weight-based dosages.​\n\nKey Uses\nMETAPECT MF KID SUSPENSION excels in managing fever associated with viral infections, teething, or post-vaccination reactions. It swiftly lowers elevated temperatures, promoting comfort and better sleep for restless kids.​\n\nFor pain relief, it tackles mild to moderate discomfort from headaches, toothaches, earaches, and sore throats common during colds or flu. Caregivers report noticeable easing of symptoms within 30-60 minutes, allowing children to resume play or eat without distress.​\n\nAdditionally, it soothes body aches, muscle strains from minor injuries, or joint pains in growing kids. In cases of post-surgical recovery or inflammatory episodes, it provides reliable support without the need for stronger opioids.​\n\nMajor Benefits\nThe primary benefit lies in its comprehensive symptom control, combining antipyretic, analgesic, and anti-inflammatory effects for holistic relief. Children experience reduced fever, less pain, and diminished swelling, leading to improved appetite and activity levels.​\n\nIts liquid suspension format ensures easy administration—no choking risks—and precise dosing prevents under- or overdosing. Flavored options like mango enhance compliance, turning medicine time into a less daunting routine for picky eaters.​\n\nCompared to alternatives, METAPECT MF KID SUSPENSION offers quicker bioavailability due to its oral liquid state, ideal for emergencies like high fever spikes at night. Long-term, it supports faster recovery by minimizing inflammation, potentially shortening illness duration when used as directed.​\n\nBenefit\tDescription:\tAdvantage over Single Agents\nFever Reduction\tLowers temperature via hypothalamic action ​\tFaster than Paracetamol alone\nPain Relief\tBlocks pain signals and prostaglandins. ​\tSuperior for inflammatory pain\nAnti-Inflammatory\tReduces swelling in tissues ​\tAddresses root cause, not just symptoms\nEasy Dosing\tLiquid with dropper for accuracy ​\tChild-friendly, no splitting tablets\nPotential Side Effects\nWhile generally well-tolerated, METAPECT MF KID SUSPENSION may cause mild gastrointestinal issues like nausea, vomiting, stomach pain, or indigestion in some children, especially if taken on an empty stomach. Administering with food can mitigate this.​\n\nLess common effects include drowsiness, dizziness, or allergic reactions such as rashes, itching, or swelling—seek immediate medical help if these occur. Prolonged use risks liver strain from Paracetamol or kidney concerns from Mefenamic Acid, so adhere strictly to prescribed durations.​\nRarely, it might lead to diarrhea, headache, or elevated liver enzymes. Monitoring is key; consult a doctor for persistent symptoms or in kids with pre-existing conditions like asthma or ulcers.​\n\nDosage Guidelines\nFollow pediatrician-recommended doses based on weight: typically 5-10ml every 6-8 hours, not exceeding 4 doses daily. Shake well before use and store below 30°C away from light.​\nAvoid in neonates under 6 months or those with hypersensitivity. Hydration and diet play roles in efficacy—pair with plenty of fluids.​\nConclusion\nMETAPECT MF KID SUSPENSION empowers parents with a dependable tool for childhood pain and fever, blending efficacy, safety, and convenience under Steris Healthcare's trusted banner. Quick relief restores normalcy, but professional oversight ensures optimal outcomes.", "price": 57.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2241, "imageuri": "https://productimages.withfloats.com/actual/693c05860443b6722a4db029.png", "tileimageuri": "https://productimages.withfloats.com/tile/693c05860443b6722a4db029.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-12T12:07:31.874Z", "updatedon": "2025-12-12T12:07:31.874Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mefenamic-acid-and-paracetamol-suspension/2241", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METAPECT MF KID SUSPENSION", "category": "PEDIATRICS", "tags": [ "Mefenamic Acid and Paracetamol Suspension", "Paracetamol", "Mefenamic Acid and 250mg Paracetamol per 5ml serving", "COX enzyme inhibition", "pain and fever", "Pain Relief" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69327c28991683751071b8b8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Polmacoxib 2mg , Paracetamol 325mg", "description": "PUMACOXIB PCM, featuring Polmacoxib 2mg and Paracetamol 325mg, delivers targeted relief from pain, inflammation, and fever associated with conditions like osteoarthritis and rheumatoid arthritis. This combination tablet works synergistically, with Polmacoxib inhibiting the COX-2 enzyme to curb inflammatory prostaglandins, while Paracetamol blocks pain signals in the brain. Patients often experience faster mobility and daily comfort from this dual-action formula.​\n\nProduct Overview and Composition\nPUMACOXIB PCM stands out as a modern pharmaceutical solution crafted for effective management of acute and chronic pain issues. Each tablet contains precisely 2mg of Polmacoxib, a selective COX-2 inhibitor that precisely targets inflammation without broadly affecting other body processes, and 325mg of Paracetamol, a trusted analgesic and antipyretic. This balanced formulation ensures comprehensive coverage against discomfort from joint disorders, muscle strains, or post-injury swelling.​\n\nThe medication's design emphasizes safety and efficacy, making it suitable for ortho patients and those with inflammatory conditions. Produced under high-quality standards, PUMACOXIB PCM offers a convenient single-dose approach to symptom control. Regular use as prescribed supports sustained joint health and reduces reliance on multiple drugs.​\n\nKey Uses of PUMACOXIB PCM\nPUMACOXIB PCM proves highly effective for osteoarthritis, particularly in hip and knee joints, where it alleviates pain, stiffness, and swelling. Rheumatoid arthritis patients benefit from its ability to ease flare-ups, improving grip strength and movement. It also addresses general body aches, back pain, and muscle soreness from injuries or overuse.​\n\nBeyond arthritis, the tablet manages post-surgical discomfort and inflammatory responses in conditions like tendonitis. For fever accompanying pain, such as in flu-related joint issues, Paracetamol component provides prompt temperature reduction. Healthcare providers often recommend it for short-term acute pain or longer-term chronic management under supervision.​\n\nMajor Benefits and Advantages\nOne primary benefit of PUMACOXIB PCM lies in its rapid onset, delivering long-lasting pain relief that enhances daily activities without constant redosing. The selective COX-2 action of Polmacoxib minimizes gastrointestinal risks compared to traditional NSAIDs, allowing safer use for stomach-sensitive individuals. Combined with Paracetamol, it offers fever control alongside anti-inflammatory effects, creating a versatile tool for multifaceted symptoms.​\n\nUsers report improved mobility and quality of life, with reduced joint stiffness enabling better exercise adherence and work productivity. Its lower side effect profile supports extended use in chronic cases, outperforming single-agent therapies in noninferiority studies against alternatives like etoricoxib combinations. Overall, PUMACOXIB PCM promotes holistic pain management with fewer disruptions to routine.​\n\nFast-acting dual relief for pain and swelling.​\n\nEnhanced joint flexibility for arthritis sufferers.​\n\nSafer stomach profile for prolonged therapy.​\n\nConvenient all-in-one tablet for busy lifestyles.​\n\nPotential Side Effects and Precautions\nWhile generally well-tolerated, PUMACOXIB PCM may cause mild effects like nausea, headache, or dizziness in some users, often resolving without intervention. Rare risks include allergic reactions such as rash or swelling, requiring immediate medical attention. Liver concerns arise with Paracetamol overuse, so adherence to dosage—one to two tablets daily—remains crucial.​\n\nAvoid alcohol to prevent liver strain, and consult doctors for kidney, liver, or heart conditions before starting. Pregnant or breastfeeding individuals should seek guidance, as should those on blood thinners or other medications. Monitoring ensures optimal safety, with most experiencing minimal issues at recommended levels.​\n\nCommon Side Effects\tLess Common Risks\tManagement Tips\nNausea, dizziness ​\tAllergic rash, swelling ​\tTake with food; hydrate well\nHeadache ​\tLiver strain (overdose) ​\tFollow dosage; avoid alcohol\nStomach discomfort ​\tHeart-related (rare) ​\tConsult for pre-existing issues\nDosage Guidelines and Best Practices\nSwallow PUMACOXIB PCM whole with water, once or twice daily, adjusting per physician advice based on pain severity. It works with or without meals, though food may ease minor stomach upset. For acute pain, short courses suffice; chronic use needs regular check-ups.​\n\nDo not exceed prescribed amounts to safeguard against Paracetamol accumulation. Store in a cool, dry place away from children. Integrating lifestyle changes like light exercise amplifies results.​\n\nConclusion\nPUMACOXIB PCM with Polmacoxib 2mg and Paracetamol 325mg transforms pain management by blending potent anti-inflammatory and analgesic actions into one reliable tablet. Its benefits in reducing inflammation, easing pain, and boosting mobility make it ideal for arthritis and related woes, all while prioritizing a favorable safety profile. Choose PUMACOXIB PCM for empowered, discomfort-free living—consult your healthcare provider today to integrate it into your wellness plan.​", "price": 295.0, "discountamount": 89.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2232, "imageuri": "https://productimages.withfloats.com/actual/69327c296111c1dae707ef57.png", "tileimageuri": "https://productimages.withfloats.com/tile/69327c296111c1dae707ef57.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-05T06:31:04.077Z", "updatedon": "2025-12-05T06:31:04.077Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/polmacoxib-2mg-paracetamol-325mg/2232", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PUMACOXIB PCM", "category": "ORTHOPEDICS RANGE", "tags": [ "Polmacoxib 2mg and Paracetamol 325mg", "Paracetamol blocks pain signals in the brain", "PUMACOXIB PCM,", "Polmacoxib 2mg and Paracetamol 325mg transforms pain" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "692ebab58b1b9a33636fefc6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Polmacoxib 2mg", "description": "Polmacoxib 2 mg capsules represent a targeted selective COX-2 inhibitor designed specifically for managing pain and inflammation in conditions like osteoarthritis, rheumatoid arthritis, and chronic joint issues. Each capsule delivers 2 mg of Polmacoxib, offering once-daily dosing for convenient, long-term use with a reduced risk of gastrointestinal complications compared to traditional NSAIDs. This formulation supports joint health by inhibiting the COX-2 enzyme responsible for producing prostaglandins that trigger pain, swelling, and stiffness.​\nTherapeutic Uses of Polmacoxib 2mg\nPolmacoxib 2 mg excels in treating osteoarthritis of the hip and knee, where cartilage breakdown leads to joint pain and reduced mobility. Healthcare providers prescribe it to alleviate symptoms of rheumatoid arthritis, ankylosing spondylitis, acute injuries like sprains, postoperative swelling, and chronic inflammatory disorders. By focusing on inflammation at its source, it helps patients regain daily functionality, from walking without stiffness to performing routine tasks with less discomfort.​\nThe medication proves particularly valuable for active individuals or those in later years seeking mobility support. It addresses post-surgery inflammation and muscle strains by quickly reducing localized swelling and pain, promoting faster recovery. Standard administration involves one 2mg capsule daily, with or without food, as directed by a physician to optimize absorption and efficacy.​\nKey Benefits and Advantages\nPolmacoxib 2mg stands out for its selective COX-2 inhibition, sparing the COX-1 enzyme that protects the stomach lining, thus minimizing risks like ulcers and bleeding common in non-selective NSAIDs. Patients experience rapid pain relief alongside improved joint flexibility, enabling better movement and reduced stiffness for enhanced quality of life.​\n\nEffective inflammation control targets swelling in osteoarthritis and rheumatoid arthritis, preserving cartilage and supporting long-term joint function.​\n\nLower gastrointestinal risks make it suitable for extended use, ideal for chronic conditions without frequent stomach upset.​\n\nConvenient once-daily dosing boosts adherence, while potential cardiovascular safety offers reassurance for those with heart concerns when used appropriately.​\n\nPromotes mobility in aging populations, reducing wear on joints and aiding independence during daily activities.​\n\nCompared to older NSAIDs, Polmacoxib provides comparable efficacy with a safer profile for prolonged therapy.​\n\nPotential Side Effects and Precautions\nWhile generally well-tolerated, Polmacoxib 2mg may cause common mild effects such as nausea, headache, dizziness, or stomach discomfort, which often resolve with continued use. Metabolic changes like elevated blood pressure can occur, especially in hypertensive patients, alongside rare renal issues or allergic reactions.​\n\nSerious risks, though less frequent, include cardiovascular events like heart attack or stroke with long-term high-dose use, particularly in those with pre-existing heart disease, and potential kidney impairment. Contraindications cover third-trimester pregnancy, severe heart or kidney conditions, and allergies to NSAIDs; interactions with blood thinners, diuretics, or ACE inhibitors require monitoring. Always consult a doctor before starting, especially if combining with other medications.​\n\nAspect\tCommon Side Effects\tSerious Risks\tPrecautions\nGastrointestinal\tNausea, upset stomach\tUlcers (reduced risk)\tTake with food if needed ​\nCardiovascular\tBlood pressure rise\tHeart attack, stroke\tMonitor in heart patients ​\nRenal\tMild changes\tKidney failure (rare)\tHydrate well ​\nGeneral\tHeadache, dizziness\tAllergic reactions\tAvoid alcohol ​\nDosage Guidelines and Best Practices\nAdults typically take one 2 mg capsule once daily for osteoarthritis or related pains, adjusting based on response and tolerance under medical supervision. Swallow whole without crushing; maintain consistent timing for steady relief. For acute pain, relief starts within hours, while chronic benefits build over days.​\n\nDo not exceed the prescribed dose to avoid amplified risks. Regular checkups ensure safety, particularly for long-term users. Store in a cool, dry place away from children.​\n\nConclusion: Empower Your Joint Health with Polmacoxib 2 mg\nPolmacoxib 2 mg capsules deliver precise, effective relief for osteoarthritis, rheumatoid arthritis, and inflammatory pains, balancing potent COX-2 inhibition with a favorable safety profile for sustained use. By easing pain, curbing inflammation, and enhancing mobility, it empowers patients to reclaim active lifestyles with fewer compromises. Consult healthcare professionals for personalized advice to maximize benefits while managing risks effectively.", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2225, "imageuri": "https://productimages.withfloats.com/actual/692ebabc525aa88c1a67d995.png", "tileimageuri": "https://productimages.withfloats.com/tile/692ebabc525aa88c1a67d995.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-02T10:08:53.463Z", "updatedon": "2025-12-02T10:58:00.188Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/polmacoxib-2mg/2225", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PUMACOXIB 2 MG", "category": "", "tags": [ "Polmacoxib 2mg", "chronic joint issues", "COX-2 enzymes", "osteoarthritis of the hip and knee", "Joint Health with Polmacoxib 2 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6914248e8c1ae64991df6fc2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Paracetamol Infusion ip", "description": "Paracetamol Infusion IP is a sterile, non-pyrogenic, and clear solution of Paracetamol (Acetaminophen) formulated for intravenous administration. It is primarily used for the management of pain and fever when oral or rectal routes are not suitable, such as in hospitalized or post-operative patients. Recognized as one of the most widely used analgesic and antipyretic medications, Paracetamol Infusion IP offers rapid onset of action, consistent therapeutic effects, and excellent patient tolerance.\n\nThis formulation ensures precise and controlled delivery of Paracetamol directly into the bloodstream, allowing for faster relief and improved bioavailability compared to oral administration.\n\nComposition\n\nEach 100 mL of Paracetamol Infusion IP typically contains:\n\nParacetamol IP – 1000 mg (1% w/v)\n\nExcipients – as required for stability and isotonicity\n\nWater for Injection – q.s. to 100 mL\n\nThe infusion is usually supplied in ready-to-use glass or plastic bottles or flexible bags, ensuring sterility and ease of use in hospital settings.\n\nMechanism of Action\n\nParacetamol (acetaminophen) exerts its therapeutic effects primarily through central inhibition of prostaglandin synthesis. Unlike nonsteroidal anti-inflammatory drugs (NSAIDs), Paracetamol has minimal peripheral anti-inflammatory activity, making it a safer option for patients with gastrointestinal or platelet-related concerns.\n\nThe drug acts by:\n\nInhibiting the cyclooxygenase (COX) enzymes, particularly COX-3, within the central nervous system, thereby reducing the synthesis of prostaglandins responsible for fever and pain.\n\nModulating the endocannabinoid system and serotonergic pathways, enhancing its analgesic potential.\n\nAs a result, Paracetamol Infusion IP provides effective fever reduction (antipyretic) and pain relief (analgesic) without significant gastrointestinal irritation or bleeding risks.\n\nIndications and Uses\n\nParacetamol Infusion IP is indicated for:\n\nManagement of Fever (Pyrexia):\n\nReduces elevated body temperature in adults and children.\n\nSuitable for patients unable to take oral medication due to nausea, vomiting, or unconsciousness.\n\nRelief of Mild to Moderate Pain:\n\nEffective in conditions like headaches, dental pain, menstrual cramps, and musculoskeletal pain.\n\nCommonly used as part of multimodal pain management after surgical procedures.\n\nPost-Operative and Trauma Pain:\n\nProvides fast, reliable pain relief in surgical recovery and trauma cases where oral medication is not feasible.\n\nAdjunct Therapy:\n\nCan be used alongside opioids to enhance analgesic effect and reduce opioid requirements.\n\nDosage and Administration\n\nAdults and adolescents (>50 kg): 1 g every 6 hours, not exceeding 4 g per day.\n\nAdults and adolescents (<50 kg): Dose adjusted based on body weight, typically 15 mg/kg every 6 hours.\n\nChildren (≥10 kg): 15 mg/kg per dose every 6 hours.\n\nThe infusion should be administered over 15 minutes, using aseptic technique. Paracetamol Infusion should not be mixed with other drugs in the same IV line unless compatibility is established.\n\nKey Benefits\n\nRapid Onset of Action:\nIntravenous administration ensures faster absorption and onset of relief compared to oral or rectal forms.\n\nHigh Bioavailability:\nSince it bypasses gastrointestinal metabolism, almost the entire dose reaches systemic circulation, providing consistent therapeutic effect.\n\nConvenience in Critical Care:\nIdeal for patients who are unconscious, post-surgery, or unable to tolerate oral medications.\n\nSafe and Well-Tolerated:\nHas minimal gastrointestinal side effects and no significant effect on platelets or renal function when used within the recommended dose range.\n\nEffective Multimodal Pain Relief:\nEnhances pain control when combined with opioids, allowing reduced opioid dosage and minimizing associated risks.\n\nStable Formulation:\nThe isotonic and sterile composition ensures patient safety, stability, and reduced risk of contamination.\n\nSuitable for Broad Patient Demographics:\nCan be used in adults, elderly patients, and children under proper medical supervision.\n\nPrecautions and Warnings\n\nWhile Paracetamol Infusion IP is generally safe, the following precautions should be observed:\n\nLiver Impairment:\nUse with caution in patients with hepatic insufficiency, chronic alcoholism, or pre-existing liver disease, as Paracetamol is primarily metabolized in the liver.\n\nRenal Impairment:\nDosage adjustment may be required in severe renal dysfunction.\n\nAvoid Overdose:\nExceeding the recommended dose can lead to severe liver toxicity and, in extreme cases, hepatic failure.\n\nDrug Interactions:\nConcomitant use with other Paracetamol-containing medications increases risk of overdose.\nCaution when used with hepatotoxic drugs or alcohol.\n\nPregnancy and Lactation:\nGenerally considered safe when used under medical supervision, though benefits should outweigh potential risks.\n\nPossible Side Effects\n\nAlthough rare and usually mild, Paracetamol Infusion IP may cause:\n\nAllergic Reactions:\nSkin rash, itching, urticaria, or swelling.\n\nHypotension:\nA transient drop in blood pressure may occur during infusion in some patients.\n\nLiver Toxicity:\nOverdose or prolonged use can lead to hepatocellular injury or elevated liver enzymes.\n\nInjection Site Reactions:\nMild pain, redness, or inflammation at the infusion site.\n\nBlood Disorders (Very Rare):\nThrombocytopenia or leukopenia may occur in extremely rare cases.\n\nIf any severe reaction such as jaundice, persistent vomiting, or allergic swelling occurs, medical attention should be sought immediately.\n\nStorage and Handling\n\nStore below 30°C, protected from light and freezing.\n\nDo not use if the solution appears cloudy or contains particles.\n\nSingle-use only; discard any unused portion after opening.\n\nConclusion\n\nParacetamol Infusion IP stands as a trusted, fast-acting, and safe intravenous formulation of one of the most widely used analgesic and antipyretic agents worldwide. Its ability to deliver rapid and predictable pain and fever relief makes it invaluable in hospitals, emergency care, and post-surgical settings.\n\nWith its favorable safety profile, high efficacy, and compatibility with multimodal pain management strategies, Paracetamol Infusion IP continues to be a first-line choice for clinicians seeking a reliable and well-tolerated solution for pain and fever management.", "price": 225.0, "discountamount": 68.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2200, "imageuri": "https://productimages.withfloats.com/actual/6914248ff448eb2e5cf3b164.png", "tileimageuri": "https://productimages.withfloats.com/tile/6914248ff448eb2e5cf3b164.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-12T06:09:18.258Z", "updatedon": "2025-12-09T05:59:57.8Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/paracetamol-infusion-ip/2200", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METAPECT 1% W/V ", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6912fc8c470ec71b0ac87646", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mometasone Furoate and Formoterol Fumarate Inhaler", "description": "Mometasone Furoate and Formoterol Fumarate Inhaler is a combination respiratory medication formulated to provide effective and long-lasting control of asthma and chronic obstructive pulmonary disease (COPD). It combines two powerful active ingredients — Mometasone Furoate, a corticosteroid (anti-inflammatory), and Formoterol Fumarate, a long-acting bronchodilator (LABA). Together, these components help patients breathe easier by reducing airway inflammation and relaxing the muscles of the airways.\n\nThis dual-action inhaler is designed for maintenance therapy rather than immediate relief of acute symptoms. By targeting both inflammation and bronchial constriction, it provides a comprehensive approach to long-term respiratory management. Each inhalation delivers a precise dose to ensure consistent therapeutic results and improved lung function.\n\nMometasone Furoate and Formoterol Fumarate Inhaler is ideal for individuals who experience persistent asthma symptoms or airflow obstruction due to COPD, despite using single-ingredient inhalers.\n\nUses and Therapeutic Indications\n\nThe Mometasone Furoate and Formoterol Fumarate Inhaler is prescribed for the following respiratory conditions:\n\nAsthma (Bronchial Asthma):\n\nUsed for the long-term control and prevention of symptoms such as wheezing, breathlessness, and chest tightness.\n\nHelps reduce inflammation and airway hyperreactivity to prevent asthma attacks.\n\nChronic Obstructive Pulmonary Disease (COPD):\n\nHelps manage chronic bronchitis and emphysema by improving airflow and reducing airway inflammation.\n\nMaintenance Therapy:\n\nProvides ongoing treatment for patients whose symptoms are not adequately controlled by inhaled corticosteroids or bronchodilators alone.\n\nThis inhaler is not meant for emergency relief during sudden asthma attacks but rather as a daily maintenance therapy to control symptoms and prevent exacerbations.\n\nKey Benefits\n\nDual Mechanism of Action:\nCombines the anti-inflammatory power of Mometasone Furoate with the bronchodilating action of Formoterol Fumarate, offering complete respiratory control in one inhaler.\n\nReduces Airway Inflammation:\nMometasone Furoate suppresses the body’s inflammatory response, helping reduce swelling, mucus buildup, and irritation in the airways.\n\nLong-Lasting Bronchodilation:\nFormoterol provides fast and sustained relaxation of airway muscles, improving airflow and making breathing easier for up to 12 hours.\n\nImproves Lung Function:\nRegular use enhances pulmonary capacity, allowing patients to perform daily activities without breathing difficulty.\n\nFewer Asthma Exacerbations:\nReduces the frequency and severity of asthma attacks and flare-ups associated with COPD.\n\nConvenient Combination Therapy:\nProvides the benefits of two medications in a single device, improving compliance and simplifying treatment routines.\n\nBetter Symptom Control:\nProven to decrease wheezing, coughing, and nighttime symptoms, leading to better sleep and overall quality of life.\n\nRapid Onset of Action:\nFormoterol acts within minutes to ease breathing while Mometasone works continuously to maintain long-term inflammation control.\n\nPossible Side Effects\n\nWhile the Mometasone Furoate and Formoterol Fumarate Inhaler is well tolerated, some individuals may experience mild to moderate side effects, especially during the early phase of therapy. These include:\n\nThroat Irritation or Dryness\n\nHoarseness or Voice Changes\n\nHeadache or Dizziness\n\nCough or Upper Respiratory Tract Infections\n\nMuscle Cramps or Tremors\n\nPalpitations (Fast or Irregular Heartbeat)\n\nNausea or Mild Stomach Upset\n\nOral Thrush (Fungal Infection in the Mouth or Throat) – often preventable by rinsing the mouth with water after inhalation.\n\nPrecautions:\n\nThis inhaler is not a rescue medication; a short-acting bronchodilator should be kept on hand for sudden breathing attacks.\n\nRegular use is essential for best results — do not stop suddenly without consulting a doctor.\n\nPatients with heart conditions, hypertension, thyroid disorders, diabetes, or osteoporosis should use this medicine under medical supervision.\n\nAlways rinse the mouth after use to prevent fungal infections.\n\nConclusion\n\nThe Mometasone Furoate and Formoterol Fumarate Inhaler represents a modern, evidence-based approach to managing chronic respiratory conditions such as asthma and COPD. By combining a corticosteroid (to reduce airway inflammation) with a long-acting bronchodilator (to open the airways), it provides effective, dual-action relief that lasts throughout the day.\n\nRegular use of this inhaler helps improve breathing capacity, reduces symptom frequency, and enhances quality of life for individuals struggling with chronic lung diseases. It not only helps patients achieve better control over their respiratory symptoms but also reduces the need for emergency interventions and hospitalizations.", "price": 360.0, "discountamount": 108.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2199, "imageuri": "https://productimages.withfloats.com/actual/6912fc8e6447ec42b9808956.png", "tileimageuri": "https://productimages.withfloats.com/tile/6912fc8e6447ec42b9808956.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-11T09:06:20.511Z", "updatedon": "2025-12-09T06:02:28.002Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mometasone-furoate-and-formoterol-fumarate-inhaler/2199", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MONTASENSE F INH", "category": "ASTHMA RANGE", "tags": [ "Mometasone Furoate and Formoterol Fumarate Inhaler", "respiratory medication", "chronic obstructive pulmonary disease (COPD)", "muscles of the airways.", "respiratory control in one inhaler" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68beb577cb617ef27c577d94", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "cefpodoxime proxetil oral suspension ip 50 mg", "description": "CEPHODOXIAA 50 DS is an oral suspension containing Cefpodoxime Proxetil, a third-generation cephalosporin antibiotic. It is widely prescribed for the treatment of bacterial infections in adults and children, including infants and babies.Oral suspension form is particularly useful for children and patients who have difficulty swallowing tablets, ensuring accurate dosing and better compliance.\nComposition\nActive Ingredient: Cefpodoxime Proxetil 50 mg per 5 ml suspension\nBrand Name: CEPHODOXIAA 50 DS\nForm: Oral Suspension\nDrug Class: Cephalosporin Antibiotic\nExcipients: Flavors, sweeteners, stabilizers for palatability and suspension stability\nCefpodoxime Proxetil Oral Suspension IP Uses\nCEPHODOXIAA 50 DS is prescribed for a wide variety of bacterial infections:\nRespiratory Tract Infections\nTonsillitis, Pharyngitis\nBronchitis and Pneumonia\nEar, Nose & Throat (ENT) Infections\nAcute Sinusitis\nOtitis Media (middle ear infection)\nUrinary Tract Infections (UTIs)\nCystitis and kidney infections\nSkin & Soft Tissue Infections\nImpetigo, Cellulitis\nInfected wounds and abscesses\nOther Indications\nGonorrhea (in selected cases)\nPediatric bacterial infections where oral dosing is preferred\nFor babies and children: The oral suspension allows precise weight-based dosing, making it safe and convenient for pediatric infections.\nHow Cefpodoxime Proxetil Oral Suspension Works\nCefpodoxime Proxetil is a beta-lactam antibiotic that:\nInhibits bacterial cell wall synthesis\nWeakens bacterial cells, causing cell death\nEffective against both Gram-positive and Gram-negative bacteria\nThis mechanism helps control infections and prevents their spread.\nDosage & Administration \nInfants & Children: Dose is based on body weight and prescribed by a pediatrician.\nCommonly 5–10 mg/kg/day, divided into 2 doses daily.\nAdults: Typically 100–200 mg every 12 hours, depending on infection severity.\nAdministration Tips:\nShake the bottle well before use.\nUse the measuring cup or spoon provided for accurate dosing.\nCan be taken with or without food, but giving after meals may reduce stomach upset.\nComplete the full course even if symptoms improve.\nBenefits of Cefpodoxime Proxetil Oral Suspension\nEasy to administer for children and babies\nBroad-spectrum coverage for respiratory, urinary, and skin infections\nHelps in rapid infection control\nSafe and effective with minimal side effects when taken as prescribed\nSuspension form allows accurate weight-based dosing\nSide Effects of Cefpodoxime Proxetil Oral Suspension\nMild side effects may include:\nDiarrhea or loose stools\nNausea or vomiting\nStomach pain\nHeadache or dizziness\nSkin rash or itching\nSerious side effects (rare):\nSevere allergic reaction (swelling, rash, difficulty breathing)\nSevere diarrhea indicating Clostridium difficile infection\nLiver enzyme elevation\nSeek medical attention if any severe or persistent side effects occur.\nPrecautions & Warnings\nAvoid if allergic to cephalosporins, penicillin, or other beta-lactam antibiotics\nUse cautiously in patients with kidney or liver disease\nNot effective against viral infections like flu or common cold\nPregnant or breastfeeding women should consult a doctor before use\nAlways complete the full prescribed course to prevent antibiotic resistance\nDrug Interactions\nAntacids containing magnesium or aluminum may reduce absorption\nProton pump inhibitors (PPIs) like omeprazole\nBlood thinners (e.g., warfarin – monitor for increased bleeding risk)\nOther antibiotics may interact and alter effectiveness\nConclusion\nCEPHODOXIAA 50 DS (Cefpodoxime Proxetil Oral Suspension IP) is a safe and effective solution for treating bacterial infections in adults, children, and babies.", "price": 100.0, "discountamount": 30.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2178, "imageuri": "https://productimages.withfloats.com/actual/68beb57bed36b14275f756c2.png", "tileimageuri": "https://productimages.withfloats.com/tile/68beb57bed36b14275f756c2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-08T10:52:39.162Z", "updatedon": "2025-12-09T06:13:04.25Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cefpodoxime-proxetil-oral-suspension-ip-50-mg/2178", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CEPHODOXIAA 50 DS", "category": "Pediatric", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }